LEICA BIOSYSTEMS NEWCASTLE LTD. – Trademark Portfolio
Entity Type: 99
LEICA BIOSYSTEMS NEWCASTLE LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ULYSIS and KREATECH. The owner is based in NEWCASTLE UPON TYNE.
BALLIOL BUSINESS PARK WEST, BENTON LANE
NEWCASTLE UPON TYNE 128EW , GB
Showing of trademarks Trademarks
Trademark Classifications
LEICA BIOSYSTEMS NEWCASTLE LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does LEICA BIOSYSTEMS NEWCASTLE LTD. have?
LEICA BIOSYSTEMS NEWCASTLE LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does LEICA BIOSYSTEMS NEWCASTLE LTD. file in?
LEICA BIOSYSTEMS NEWCASTLE LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are LEICA BIOSYSTEMS NEWCASTLE LTD.'s most well-known trademarks?
LEICA BIOSYSTEMS NEWCASTLE LTD.'s registered trademark portfolio includes well-known marks such as ULYSIS and KREATECH. These are among 3 currently registered trademarks in the portfolio.
What is LEICA BIOSYSTEMS NEWCASTLE LTD.'s trademark registration success rate?
LEICA BIOSYSTEMS NEWCASTLE LTD. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.